Offer - Urjas Oil for just ₹ 1
Unitinib, a prescription drug, is manufactured in various forms such as Capsule. It is typically used for the treatment of Chronic Myelogenous Leukemia. Other than this, Unitinib has some other therapeutic uses, which have been discussed ahead.
The right dosage of Unitinib depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Some other side effects of Unitinib have been listed ahead. Usually, these side effects of Unitinib go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Unitinib has a Severe effect for pregnant women and Moderate effect on lactating mothers. Further, the section on Unitinib related warnings talks about Unitinib's effects on the liver, heart and kidney.
Other contraindications of Unitinib have been discussed in the sections ahead.
Besides this, Unitinib may also have severe interaction with some medicines. A complete list of these interactions is given below.
You should also be aware that Unitinib is not safe while driving, and is not addiction.
Unitinib is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 2 - 12 years (Child) |
|
| 13 - 18 years (Adolescent) |
|
Is the use of Unitinib safe for pregnant women?
Unitinib should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Unitinib safe during breastfeeding?
Unitinib may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Unitinib, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Unitinib.
What is the effect of Unitinib on the Kidneys?
There may be some adverse effects on kidney after taking Unitinib. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Unitinib on the Liver?
Unitinib may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Unitinib on the Heart?
The heart can be affected by Unitinib. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Unitinib should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Unitinib unless your doctor advises you to do so -
Is this Unitinib habit forming or addictive?
No, you will not get addicted to Unitinib.
Is it safe to drive or operate heavy machinery when consuming?
After taking Unitinib you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Unitinib is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Unitinib in mental disorders is not effective.
Interaction between Food and Unitinib
Taking Unitinib with food is safe.
Interaction between Alcohol and Unitinib
Due to lack of research, there is no information about the side effects of taking Unitinib with alcohol.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gleevec (imatinib mesylate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 674-676
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 869
